Answers are grounded in this paper and cite their sources.
Focal ablation therapies in prostate cancer have been actively evaluated in the light of recent literature. According to published data,focal ablation therapies appear to be well tolerated and have an acceptable side effect profile. Moreover, while clinical outcomes were not homogenous, short-term oncological results of some focal ablation therapies such as laser and irreversible electroporation (IRE) have been found as good as curative ones. While waiting long-term oncological results, focal ablation therapies in prostate cancer are beinmg used increasingly.
No takes yet. Share an insight, caveat, or question.
Öztüğ Adsan (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: